Synergistic effect of molybdate plus dithiothreitol on stabilization, reactivation, and partial purification of the kidney glucocorticoid receptor.
D000818:Animals; D003907:Dexamethasone / Q000378:metabolism; D004229:Dithiothreitol / Q000494:pharmacology*; D004355:Drug Stability; D004357:Drug Synergism; D007668:Kidney / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D008982:Molybdenum / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D011965:Receptors, Glucocorticoid / Q000187:drug effects / Q000302:isolation & purification / Q000378:metabolism*; D011987:Receptors, Steroid / Q000378:metabolism*
D011965:Receptors, Glucocorticoid; D011987:Receptors, Steroid; D003907:Dexamethasone; D008982:Molybdenum; C024687:sodium molybdate(VI); D004229:Dithiothreitol